Max Robotics — Global Service Robot Directory + US Certification

About

Koji Kawakami is a surgical outcomes researcher whose work focuses on perioperative safety and complication risk in urologic and head and neck cancer surgery. His key research areas include the impact of antiplatelet therapy on bleeding complications in robot-assisted radical prostatectomy, as well as risk factor analysis for adverse events following transoral surgeries for pharyngolaryngeal cancer. In his most cited study (7 citations, 2024), Kawakami led a cohort analysis using a national robotic surgery database to assess how thienopyridine-class antiplatelet agents—ticlopidine, clopidogrel, and prasugrel—affect bleeding outcomes, providing critical evidence for perioperative medication management. His subsequent work (2025) examined complication risk factors in non-robotic transoral procedures using nationwide claims data, contributing to safer surgical protocols. By leveraging large-scale real-world data, Kawakami’s research directly informs clinical decision-making for high-risk surgical patients. His findings are particularly valuable for surgeons and anesthesiologists balancing thrombotic risk with bleeding risk in cancer patients. With a growing citation impact, Kawakami is establishing himself as a methodologically rigorous voice in surgical safety and outcomes research.